<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T15:39:44Z</responseDate>
  <request identifier="oai:figshare.com:article/34021673" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34021673</identifier>
        <datestamp>2026-09-29T07:00:04Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Scorpion-Inspired 1,3,4-Oxadiazole-Based GSK-3β-Targeting Agents: Design, Synthesis, and Biological Evaluation</dc:title>
          <dc:creator>Mustafa Cakir (6330182)</dc:creator>
          <dc:creator>Eda Acikgoz (816259)</dc:creator>
          <dc:creator>Burak Kuzu (12876169)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>GSK-3β</dc:subject>
          <dc:subject>oxadiazole</dc:subject>
          <dc:subject>phenacylthio derivatives</dc:subject>
          <dc:subject>scorpion-inspired design</dc:subject>
          <dc:subject>anticancer activity</dc:subject>
          <dc:subject>spheroid model</dc:subject>
          <dc:description>&lt;p&gt;Glycogen synthase kinase-3β (GSK-3β) is a promising therapeutic target for anticancer drug development because it is involved in cell proliferation, apoptosis, and tumor progression. However, developing structurally distinct GSK-3β-directed anticancer scaffolds with favorable cancer-cell selectivity remains challenging. In this study, 10 scorpion-inspired 2-(phenacylthio)-1,3,4-oxadiazole derivatives (&lt;b&gt;ODS1-10&lt;/b&gt;) were synthesized in 65–97% yields and evaluated for their anticancer potential. Among the synthesized compounds, &lt;b&gt;ODS-7&lt;/b&gt; showed the highest activity against MDA-MB-231 cells (IC&lt;sub&gt;50&lt;/sub&gt; = 32.7 μM), whereas &lt;b&gt;ODS-5&lt;/b&gt; was the most active derivative against SH-SY5Y cells (IC&lt;sub&gt;50&lt;/sub&gt; = 21.2 μM). Structure–activity relationship analysis indicated that the electronic properties and substitution pattern of the aryl moieties substantially influenced antiproliferative activity. &lt;b&gt;ODS-5&lt;/b&gt; and &lt;b&gt;ODS-7&lt;/b&gt; showed preferential activity toward cancer cells, with &lt;b&gt;ODS-5&lt;/b&gt; exhibiting a selectivity index of 2.80 against non-cancerous HaCaT keratinocytes. Both compounds significantly reduced SH-SY5Y clonogenic capacity and disrupted three-dimensional spheroid integrity. Immunofluorescence analysis revealed reduced GSK-3β-associated fluorescence intensity in treated SH-SY5Y cells, while RT-qPCR demonstrated upregulation of BAX and CASP3 and downregulation of BCL2, supporting the involvement of apoptosis in the observed cytotoxic response. Molecular docking also showed favorable predicted binding energies for &lt;b&gt;ODS-5&lt;/b&gt; (−8.67 kcal/mol) and &lt;b&gt;ODS-7&lt;/b&gt; (−8.44 kcal/mol) within the GSK-3β binding site, comparable to the co-crystallized ligand 3HT (−8.37 kcal/mol). Overall, &lt;b&gt;ODS-5&lt;/b&gt; and &lt;b&gt;ODS-7&lt;/b&gt; represent promising preliminary lead structures within the 2-(phenacylthio)-1,3,4-oxadiazole series, providing a rational SAR basis for further medicinal chemistry optimization and direct evaluation of GSK-3β target engagement.&lt;/p&gt; &lt;p&gt;Multi-panel diagram depicting a scorpion-inspired design, synthesized derivatives, target engagement with GSK-3ß, and mechanistic marker results.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T07:00:04Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34021673.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Scorpion-Inspired_1_3_4-Oxadiazole-Based_GSK-3_-Targeting_Agents_Design_Synthesis_and_Biological_Evaluation/34021673</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
